1.EFFECTS OF SINOMENINE ON ISOPRENALINE AND CALCIUM MEDIATED POSITIVE CHRONOTROPIC ACTION
Chinese Pharmacological Bulletin 1987;0(01):-
The effects of sinomenine (Sin) on isoprenaline and hist ami no dose-response relationships and calcium-mediated positive chronotro-pic time-response relationship were studied in isolated guinea-pig ri^lil atritui. Sin shifted isoprenaline and histamine doseresponse cuives to the right non-parallely and depressed their maximum and produced a noncompetitive antagonism. The pD'2 values were 3.48+ 0.08 and 3.63+0.04, respectively. It was different from B-receptor blocker propranolol and H2-receptor blocker cimetidinc. Sin as well as verapamil antagonized the positive chronotropic response to CaCl2. These results suggested that the negative chrouotropic effects of Sin did not result from blocked |3-and H2-receptor, but probably from antagonizing Ca2+ channel.
2.EFFECTS OF SINOMENINE ON ISOLATED GUINEA-PIG AURICLE
Chaoxing LI ; Gengsheng ZHAO ;
Journal of Xi'an Jiaotong University(Medical Sciences) 1982;0(01):-
After Sinomenine 27 ?M was given, the contractibility was decreased to 51?11% (SD) and dT/dt max to 50?14% (SD). The automaticity induced by epinephrine was inhibited. Sinomenine (2.7-270 ?M) caused a concentration-dependent prolongation in the functional period. The amplitude of contraction and the heart rate in the right auricle was also inhibited. The results indicate that sinomenine may be antogonistic to both Ca~(++) influx and inward Na~(++) current.
3.The effect of different combinations between irradiation and cisplatin or lobaplatin on tumor growth in mice
Mingxia SUN ; Hongzhen LI ; Xianshu GAO ; Shangbin QIN ; Chaoxing LIU ; Min ZHANG ; Jing ZHAO ; Xiaomei LI ; Yuliang ZHAO
Chinese Journal of Radiation Oncology 2011;20(4):351-354
Objective To learn the effect of different combination model between irradiation and cisplatin or lobaplatin on the radiosensitization of xenographt tumor in mice.Methods Seventy C57BL/6 mice with Lewis lung carcinoma were randomly divided into fourteen groups.Then a single intravenous bolus injection of 10 mg/kg either cisplatin or lobaplatin was given.Tumor tissues were collected at the indicated times of 0.5 h, 2.0 h, 4.0 h, 24.0 h, 48.0 h, 72.0 h, and 96.0 h.The platinum levels were determined by inductively coupled plasma-mass spectrometry.Eighty tumor-bearing mice were randomly divided into 10 groups, including a blank control group, a irradiation group, two drug treatment groups and 6 combined treatment groups.The tumors were irradiated at 1 h, 24 h or 72 h after either cisplatin or lobaplatin injection.The tumor size of the groups was compared.Results The concentrations of cisplatin and lobaplatin in tumors rapidly reached 4.78 μg/g and 2.79 μg/g (t=3.82,P=0.005), respectively, then declined rapidly to 3.39 μg/g and 0.99 μg/g (t=9.10,P=0.000) at 4 h, 1.41 μg/g and 0.23 μg/g (t=3.70,P=0.006) at 96 h, respectively.The tumor growth among the three groups of irradiation at 1 h, 24 h or 72 h after cisplatin was similar, which was slower than the blank control group, the irradiation group and the cisplatin treatment group.At the 15th day, the relative volume of tumor in the three combined treatment groups were 4.73, 5.52 and 2.15(F=0.84,P=0.451), While was 16.63(F=10.50,P=0.000) in the blank control group, 10.34(F=3.12,P=0.046) in the irradiation group, and 12.80(F=8.06,P=0.001) in the cisplatin treatment group, respectively.The tumor growth among the three groups of irradiation at 1 h, 24 h or 72 h after lobaplatin was also similar, which was slower than the blank control group, the irradiation group and the lobaplatin treatment group.At the 15th day, the relative volume of tumor in the three combined treatment groups were 3.49, 4.90 and 3.86(F=0.32,P=0.727), While was 16.63(F=15.21,P=0.000) in the blank control group, 10.34(F=4.12,P=0.016) in the irradiation group, and 14.28(F=10.67,P=0.000) in the lobaplatin treatment group, respectively.The sensitizing enhancement ratio (SER) at 1 h, 24 h and 72 h after the injection were 2.13, 2.03 and 3.45 of cisplatin, and 2.53, 2.00 and 2.50 of lobaplatin, respectively.Conclusions After intravenous bolus injection, the cisplatin concentration in the tumor can be kept at least 96 hours, which results in a persistent radiosensitizing effect.Lobaplatin and cisplatin have similar anti-tumor and radiosensitizing effect.
4.Studies on the toxic effects of magnetic targeting adriamycin-carboxymethyldextran magnetic nanoparticles.
Keyu SHI ; Chaoxing LI ; Binglin HE
Journal of Biomedical Engineering 2003;20(2):219-221
In this paper, adriamycin-carboxymethyldextran magnetic nanoparticles (ADR-CMD MNPs) were prepared. After i.v. administration in mice, acute toxicity, cumulative toxicity and the distribution profiles of heart were studied both for free adriamycin(ADR) and ADR-CMD MNPs. The results showed conjugation with CMD MNPs, the acute toxicity of ADR was decreased significantly, the LD50 value of ADR-CMD MNPs was 5.06 times as high as that of the free ADR. Altogether, the cumulative toxicity of conjugate MNPs is significantly decreased as expressed by the mortality, the loss for both weight and leucocyte after repeated injection. Tissue distribution studies show the reduced cardiac uptake of ADR after i.v. which possibly contributes to minimizing the cardiotoxic effect of ADR.
Animals
;
Dextrans
;
Doxorubicin
;
administration & dosage
;
pharmacokinetics
;
toxicity
;
Drug Carriers
;
Drug Delivery Systems
;
Female
;
Injections, Intravenous
;
Magnetics
;
Male
;
Mice
;
Myocardium
;
metabolism
;
Tissue Distribution
5.Progress in the Application of Non-cell-based Permeation Model in the Study of the Permeability of BSC Class Ⅱ Drugs
Wenna WU ; Li DING ; Zhongliang FENG ; Xiaoming HE ; Chaoxing HE ; Yu FANG
Chinese Journal of Modern Applied Pharmacy 2024;41(8):1135-1141
Permeability is one of the determinants of intestinal absorption and oral bioavailability. The non-cell-based permeation model is a kind of in vitro permeability measurement tool, which has the advantages of high efficiency, low cost, stable property, easy to use and customizable. According to the barrier type, non-cell-based permeation model can be divided into biomimetic barriers containing (phosphate) lipids and non-biomimetic barriers without lipids. Biomimetic permeation models include parallel artificial membrane permeability assay, vesicle-based permeation assay and PermeaPad®. Non biomimetic permeation models include Hollow fiber membrane models based on polyether sulfone materials. In foreign countries, the application of these four barriers for different purposes is gradually becoming a hot spot in drug absorption research. However, in China, there are only more applied studies on PMAPM and few published applied studies on the other three barriers. In order to meet the development needs of insoluble drug formulations, the author summarized the permeability devices and permeability calculation methods, searched the application of non-cell-based permeation model in the permeability of BSCⅡ drugs in recent years, and summarized the characteristic applications of three Biomimetic permeation models and hollow fiber membranes.